[HTML][HTML] Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - cell.com
Summary Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …

[HTML][HTML] Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - Elsevier
Summary Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis.

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - europepmc.org
SUMMARY Trimethylamine N-oxide (TMAO), a gut microbiota dependent metabolite, both
enhances atherosclerosis in animal models and is associated with cardiovascular risks in …

[PDF][PDF] Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - stritch.luc.edu
SUMMARY Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …

[PDF][PDF] Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - lumen.luc.edu
SUMMARY Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - pubmed.ncbi.nlm.nih.gov
Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite, both
enhances atherosclerosis in animal models and is associated with cardiovascular risks in …

[引用][C] Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - cir.nii.ac.jp

[PDF][PDF] Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - sochob.cl
SUMMARY Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite,
both enhances atherosclerosis in animal models and is associated with cardiovascular risks …

[HTML][HTML] Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - ncbi.nlm.nih.gov
SUMMARY Trimethylamine N-oxide (TMAO), a gut microbiota dependent metabolite, both
enhances atherosclerosis in animal models and is associated with cardiovascular risks in …

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Z Wang, AB Roberts, JA Buffa, BS Levison, W Zhu… - Cell, 2015 - infona.pl
Trimethylamine (TMA) N-oxide (TMAO), a gut-microbiota-dependent metabolite, both
enhances atherosclerosis in animal models and is associated with cardiovascular risks in …